Maraat, Reggie Ann B.

HRN: 25-33-42  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2024
CEFTRIAXONE 1G (VIAL)
07/03/2024
07/12/2024
IVT
2g
Q12
T/c Meningitis
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Central Nervous System    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes